Herzich Paul
Chief Technology Officer
Herzich Paul has filed 4 SEC Form 4 filings (8 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Feb 18, 2026.
On the most recent filing, Herzich Paul is listed as Chief Technology Officer at Solid Biosciences Inc. Inside the rolling window, Herzich Paul reported no open-market purchases and 4 open-market sales totaling $274K in SLDB. The largest disclosed transaction in the window is a sale of 26,250 SLDB shares on Feb 2, 2026, worth $169K.
Companies traded
Other insiders at SLDB
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$274K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Herzich Paul made?
Herzich Paul has filed 4 SEC Form 4 filings (8 transaction rows) across 1 company since 2025.
Which companies does Herzich Paul trade?
Herzich Paul has filed SEC Form 4 disclosures for 1 company, including SLDB.
When was Herzich Paul's most recent SEC Form 4 filing?
Herzich Paul's most recent SEC Form 4 filing on Tracefour is dated Feb 18, 2026.
What is Herzich Paul's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Herzich Paul is listed as Chief Technology Officer.
What is Herzich Paul's total buy and sell value in the current window?
Inside the rolling retention window, Herzich Paul bought $0 and sold $274K based on SEC Form 4 filings.
What was Herzich Paul's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 26,250 SLDB shares on 2026-02-02, worth $169K, per SEC Form 4 filings.